- News Highlight
Blue Ribbon Study Panel on Biodefense is now the Bipartisan Commission on Biodefense
Now in its 5th year, the Blue Ribbon Study Panel on Biodefense is taking on a new name to more accurately reflect its work and the urgency of its mission. Effective immediately, the organization now will be known as the Bipartisan Commission on Biodefense.
More18 September, 2019
Commission
The Blue Ribbon Study Panel on Biodefense discusses the growing pandemic threat and the steps the United States government needs to take in order to keep America safe. Their discussion is moderated by best-selling author Max Brooks.
February 12, 2020
“We have to plan for the possibility that we have thousands of coronavirus cases in the U.S.,” – Dr. Asha M. George to Congress
The U.S. Senate Committee on Homeland Security and Governmental Affairs today hosted a roundtable discussion called, Are We Prepared? Protecting the U.S. from Global Pandemics. Dr. Asha M. George, Executive Director of the Bipartisan Commission on Biodefense was among five experts invited to participate.
February 11, 2020
OPINION One mutation away from disaster: Coronavirus exposes a huge weakness in our national preparedness
Our inattentiveness as a nation to biodefense has resulted in this alarming truth: We are one mutation away from biological disaster. Just one genetic change and a virus like coronavirus or influenza can become far more contagious and lethal, or the antibiotics we depend on to kill bacteria can be rendered ineffective. When the Bipartisan Commission on Biodefense, which we co-chair, was established five years ago, its goal was to assess America’s ability as a nation to defend against biological threats from terrorists, nation-states, accidents and nature that could affect our national security.
February 11, 2020
The coronavirus outbreak: 3 ways the United States was (and is) unprepared
In a wide-ranging discussion, Asha George, a biosecurity expert and executive director of the Bipartisan Commission on Biodefense and a member of the Bulletin’s Science and Security Board talked about where she thinks the government is falling short in its response to the coronavirus and other biological threats.
February 3, 2020
Wuhan Coronavirus Could Test the Trump Administration’s Ability to Respond to a Crisis. Experts are Worried
“Once you have multiple agencies and departments involved, you have to have somebody at the White House who is who is informed, who has had some experience, and understands what all of these departments and agencies are supposed to do and can bring them together, and do the staffing and represent the President,” said Asha George, executive director of the Bipartisan Commission on Biodefense.
January 30, 2020
Larsen, Langevin and Carson Introduce Legislation to Better Protect Americans From the Flu
“When we first released our National Blueprint for Biodefense in 2015, we noted that the root cause of our nation’s continuing vulnerability to influenza and other biological threats was the lack of strong centralized leadership at the highest level of government,” said Dr. Asha M. George, Executive Director, Bipartisan Commission on Biodefense.
January 30, 2020
The Coronavirus Is Now Officially a Global Emergency
Despite these numbers, overall funding for public health in general has fallen during both the Obama and Trump administrations, and the current appropriations aren’t enough to handle a serious epidemic, says Asha George, executive director of the Bipartisan Commission on Biodefense, a think tank that advises Congress on public health and security
